Company / Free Cash Flow
Baxter International Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$332.0M
FY2025
5-year range
$332.0M / $1.5B
FY2021-FY2025
Trend
-42.1%
vs FY2024
Sector context
#52 of 151
Health Care
What the data says
At $332M, Baxter International's free cash flow ranks #52 of 151 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from $332M in FY2025 to $2.3B in FY2016.
Based on SEC 10-K filings.
$332M in FY2025 with a 5-year CAGR of -22.1%.
Declined from $1.3B to $332M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -26.4%
- 5-Year CAGR
- -22.1%
- 10-Year CAGR
- -
Sector benchmark
#52 of 151 in Health CareTop 34% of 151This company $332.0M Sector average $779.8M
▼
-57.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -22.1%, indicating a declining trend.
- In FY2025, free cash flow decreased 42.1% year-over-year.
- Ranks #52 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2016.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $332.0M | -42.1% |
| FY2024 | $573.0M | -55.7% |
| FY2023 | $1.3B | +55.2% |
| FY2022 | $834.0M | -45.5% |
| FY2021 | $1.5B | +32.1% |
| FY2020 | $1.2B | +5.6% |
| FY2019 | $1.1B | -19.1% |
| FY2018 | $1.4B | +23.7% |
| FY2017 | $1.1B | -52.1% |
| FY2016 | $2.3B | +166.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026